Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Crane Company | CR | Jan 17, 2025 | 156.00 | +0.35 |
Crane NXT | CXT | Jan 17, 2025 | 63.72 | +0.46 |
Crawford & Company A | CRD-A | Jan 17, 2025 | 12.08 | -0.82 |
Crawford & Company B | CRD-B | Jan 17, 2025 | 11.94 | -0.91 |
Creative Global Technology | CGTL | Jan 17, 2025 | 5.30 | 0.00 |
Creative Media & Community Trust | CMCT | Jan 17, 2025 | 0.75 | -3.61 |
Creative Medical Technology | CELZ | Jan 17, 2025 | 2.27 | +4.13 |
Creative Realities | CREX | Jan 17, 2025 | 2.53 | +1.61 |
Credicorp | BAP | Jan 17, 2025 | 182.14 | -2.47 |
Credit Acceptance | CACC | Jan 17, 2025 | 484.82 | +0.54 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Jan 17, 2025 | 26.37 | 0.00 |
Credit Suisse Ag | SLVO | Jan 17, 2025 | 76.53 | -0.91 |
Credit Suisse Ag | GLDI | Jan 17, 2025 | 157.80 | +0.32 |
Credit Suisse Asset Management Income Fund | CIK | Jan 17, 2025 | 2.93 | +0.69 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Jan 17, 2025 | 67.58 | -0.03 |
Credit Suisse High Yield Bond Fund | DHY | Jan 17, 2025 | 2.13 | +1.43 |
Credo Technology | CRDO | Jan 17, 2025 | 80.02 | +5.85 |
Crescent Capital BDC | CCAP | Jan 17, 2025 | 19.34 | -0.10 |
Crescent Energy | CRGY | Jan 17, 2025 | 16.62 | -0.72 |
Cresud A ADR | CRESY | Jan 17, 2025 | 12.09 | -2.66 |
Crexendo | CXDO | Jan 17, 2025 | 5.35 | +0.94 |
CRH | CRH | Jan 17, 2025 | 97.75 | +2.26 |
Cricut A | CRCT | Jan 17, 2025 | 5.73 | -0.87 |
Crinetics Pharmaceuticals | CRNX | Jan 17, 2025 | 37.35 | +2.38 |
CRISPR Therapeutics | CRSP | Jan 17, 2025 | 40.53 | +0.57 |
Criteo ADR | CRTO | Jan 17, 2025 | 37.68 | +0.53 |
Critical Metals | CRML | Jan 17, 2025 | 8.50 | +12.14 |
Crocs | CROX | Jan 17, 2025 | 99.97 | -2.63 |
Cronos Group | CRON | Jan 17, 2025 | 1.99 | +1.02 |
Cross Country Healthcare | CCRN | Jan 17, 2025 | 18.18 | +0.33 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.